FIVE-YEAR OUTCOMES WITH ALEMTUZUMAB INDUCTION AFTER LUNG TRANSPLANTATION

BACKGROUND: Induction therapy with alemtuzumab, followed by lower than conventional intensity posttransplant immunosuppression (e.g., tacrolimus monotherapy), has been associated with reduced morbidity and mortality in abdominal and heart transplantation. We examined 5-year outcomes in lung recipien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shyu, Susan, Dew, Mary Amanda, Pilewski, Joseph M., DeVito Dabbs, Annette J., Zaldonis, Diana B., Studer, Sean M., Crespo, Maria M., Toyoda, Yoshiya, Bermudez, Christian A., McCurry, Kenneth R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110582/
https://ncbi.nlm.nih.gov/pubmed/21420318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healun.2011.01.714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados